TSG-6 inhibits osteoclast activity via an autocrine mechanism and is functionally synergistic with osteoprotegerin

Osteoclasts Have Multiple Roles in Bone in Addition to Bone Resorption

(2012) Brendan Boyce et al.   CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION

Functions of nuclear factor κB in bone

(2010) Brendan F. Boyce et al.   Annals of the New York Academy of Sciences

IL-17 induces osteoclastogenesis from human monocytes alone in the absence of osteoblasts, which is potently inhibited by anti-TNF-α antibody: A novel mechanism of osteoclastogenesis by IL-17

(2009) Toru Yago et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

NF-κB p100 limits TNF-induced bone resorption in mice by a TRAF3-dependent mechanism

(2009) Zhenqiang Yao et al.   JOURNAL OF CLINICAL INVESTIGATION

Coregulation in human leukocytes of the long pentraxin PTX3 and TSG-6

(2009) Virginia Maina et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Cytokine-controlled RANKL and osteoprotegerin expression by human and mouse synovial fibroblasts: Fibroblast-mediated pathologic bone resorption

(2008) Miklos Tunyogi-Csapo et al.   ARTHRITIS AND RHEUMATISM

TSG-6 Regulates Bone Remodeling through Inhibition of Osteoblastogenesis and Osteoclast Activation

(2008) David J. Mahoney et al.   JOURNAL OF BIOLOGICAL CHEMISTRY